Management of oral Kaposi's sarcoma and a proposal for clinical staging

Oral Diseases

Volumn 3, Issue SUPPL. 1, 1997, Pages

  Epstein, J B ^a,b,c,d  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Management and staging of oral Kaposi's sarcoma

Indexed keywords

ANALGESIC AGENT; BLEOMYCIN; CYTOTOXIC AGENT; DOXORUBICIN; LIPOSOME; RECOMBINANT ALPHA2A INTERFERON; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM; VINBLASTINE; VINBLASTINE SULFATE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PROTOCOL; CONFERENCE PAPER; ENCAPSULATION; EXCISION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION PAIN; INTRALESIONAL DRUG ADMINISTRATION; KAPOSI SARCOMA; MOUTH CANCER; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030915482     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00342.x     Document Type: Conference Paper

References (28)

1. Chak LY, Gill PS, Levine AM et al (1988). Radiation therapy for acquired immuno-deficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 6: 863-867.
2. Cooper JS, Freid PR (1987). Toxicity of oral radiotherapy in patients with acquired immunodeficiency syndrome. Arch Otolaryngol Head Neck Surg, 113: 327-328.
3. Cooper JS, Freid PR, Laubenstein LJ (1984). Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma. J Am Med Assoc 252: 934-935.
4. Epstein JB (1993). Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer 71: 1722-1725.
5. Epstein JB, Lozada-Nur F, McLeod A et al (1989). Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Cancer 1989; 64: 2424-2430.
6. Epstein JB, Scully C (1991). HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 71: 38-41.
7. Epstein JB, Scully C (1989). Intralesional vinblastine for oral Kaposi's sarcoma in HIV infection. Lancet 11: 1100-1110.
8. Epstein JB, Silverman S Jr (1992). Head and neck malignancies associated with HIV infection. Oral Surg Oral Med Oral Pathol 73: 193-200.
9. Feigal DW, Katz MH, Greenspan D et al (1991). The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5: 519-535.
10. Ficarra G, Berson AM, Silverman S Jr et al (1988). Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment. Oral Surg Oral Med Oral Pathol 66: 543-550.
11. Ficarra G, Eversole LE (1994). HIV-related tumors of the oral cavity. Crit Rev Oral Biol Med 5: 159-185.
12. Flaitz CM, Nichols CM, Hicks MJ (1995). An overview of the oral manifestations of AIDS-related Kaposi's sarcoma. Compendium 16: 136-138, 140, 142.
13. Gill PS (1991). Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Sem Oncol 18: 53-57.
14. Lafferty WE, Glidden D, Hopkins SG (1991). Survival trends of people with AIDs in Washington state. Am J Pub Health 2: 217-219.
15. LeBourgeois JP, Frikha H, Piedbois P et al (1994). Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 30: 263-266.
16. Lucatorto FM, Sapp JP (1993). Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. A preliminary study. Oral Surg Oral Med Oral Pathol 75: 192-198.
17. McCormick SU, Intriere N, Sanchez M et al (1992). Vinblastine injection in the treatment of Kaposi sarcoma. J Oral Maxillofac Surg 50 (Suppl): 114-115.
18. McCormick SU (1996). Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up. J Oral Maxillofac Surg, 54: 583-587.
19. Moyle G, Youle M, Barton S (1993). Intralesional vinblastine in the treatment of oral Kaposi's sarcoma. Br J Clin Pract 47: 79-80.
20. Muzyka BC, Glick M (1993). Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS. New Engl J Med 328: 210-221.
21. Nichols CM, Flaitz CM, Hicks MS (1993). Treating Kaposi's lesions in the HIV-infected patient. J Am Dent Assoc 124: 78-84.
22. Nobler MP, Leddy ME, Huh SH (1987). The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome. J Clin Oncol 5: 107-112.
23. Northfelt DW (1994a). Treatment of Kaposi's sarcoma. Current guidelines and future perspectives. Drugs 48: 569-582.
24. Payne SF, Lemp GF, Rutherford GW (1990). Survival following diagnosis of Kaposi's sarcoma for AIDS patients in San Francisco. J Acquir Immune Defic Syndr 3 (Suppl 1): 14-17.
25. Piedbois P, Frikha H, Martin L et al (1994). Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 30: 1207-1211.
26. Reichart PA, Langaford-Kuntz A, Pohle H-D (1993). Epidemic oro-facial Kaposi's sarcoma (eKS)-Report on 124 cases. Oral Oncol, Eur J Cancer 29B, 187-189.
27. Sulis E, Floris C, Sulis ML et al (1989). Interferon administered intralesionally in skin and oral cavity lesion in heterosexual drug addicted patients with AIDS-related Kaposi sarcoma. Eur J Cancer Clin Oncol 25: 756-761.
28. Tabata M, Langford A, Becker J et al (1993). Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS). Oral Oncol, Euro J Cancer 29(B): 209-213.